{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:30:46Z","timestamp":1791192646507,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.lfs.2006.01.007","type":"journal-article","created":{"date-parts":[[2006,2,10]],"date-time":"2006-02-10T12:29:39Z","timestamp":1139574579000},"page":"317-323","source":"Crossref","is-referenced-by-count":9,"title":["In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters"],"prefix":"10.1016","volume":"79","author":[{"given":"Orsolya","family":"T\u00f3th","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Kecsk\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"P\u00f3t\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajna","family":"Losonczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2006.01.007_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00005344-200403000-00014","article-title":"Inhibition of ADP-evoked platelet aggregation by selected poly(ADP-ribose) polymerase inhibitors","volume":"43","author":"Alexy","year":"2004","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.lfs.2006.01.007_bib2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/197974a0","article-title":"Effect of adenosine diphosphate on the concentration of platelets in circulating blood","volume":"197","author":"Born","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2006.01.007_bib3","first-page":"8","article-title":"A new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time","volume":"2","author":"Boudjeltia","year":"2002","journal-title":"BioMed Central Biotechnology"},{"issue":"3","key":"10.1016\/j.lfs.2006.01.007_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1523-1755.1999.00644.x","article-title":"Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress","volume":"56","author":"Chatterjee","year":"1999","journal-title":"Kidney International"},{"issue":"11","key":"10.1016\/j.lfs.2006.01.007_bib5","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.5858\/2000-124-1657-POHIT","article-title":"Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications \u2014 a review","volume":"124","author":"Fabris","year":"2000","journal-title":"Archives of Pathology and Laboratory Medicine"},{"issue":"5244","key":"10.1016\/j.lfs.2006.01.007_bib6","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1126\/science.270.5244.2017","article-title":"The effect of sodium salicylate and aspirin on NF-kappa B","volume":"270","author":"Frantz","year":"1995","journal-title":"Science"},{"issue":"3 Suppl","key":"10.1016\/j.lfs.2006.01.007_bib7","doi-asserted-by":"crossref","first-page":"513S","DOI":"10.1378\/chest.126.3_suppl.513S","article-title":"Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Harrington","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2006.01.007_bib8","series-title":"25th International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, March 21\u201325, 2005","first-page":"199","article-title":"Selective poly(ADP-ribose)-polymerase inhibition affects neither DNA repair nor cell senescence after ischemia\u2013reperfusion","volume":"vol. 9 (Suppl 1)","author":"Hauser","year":"2005"},{"issue":"4","key":"10.1016\/j.lfs.2006.01.007_bib9","first-page":"347","article-title":"Methods of studying platelet function. Biological markers of the activation of human platelets in vivo and in vitro","volume":"44","author":"Hemmendinger","year":"1986","journal-title":"Annales de Biologie Clinique (Paris)"},{"issue":"5","key":"10.1016\/j.lfs.2006.01.007_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrd1718","article-title":"Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors","volume":"4","author":"Jagtap","year":"2005","journal-title":"National Reviews. Drug Discovery"},{"issue":"16","key":"10.1016\/j.lfs.2006.01.007_bib11","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1021\/jm0502891","article-title":"Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone","volume":"48","author":"Jagtap","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.lfs.2006.01.007_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000025949","article-title":"Protection against hydrogen peroxide induced injury in renal proximal tubule cell lines by inhibition of poly(ADP-ribose) synthase","volume":"23","author":"Jung","year":"2000","journal-title":"Kidney and Blood Pressure Research"},{"issue":"2","key":"10.1016\/j.lfs.2006.01.007_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1072-7515(03)00538-6","article-title":"Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass","volume":"197","author":"Khan","year":"2003","journal-title":"Journal of American College of Surgery"},{"issue":"3","key":"10.1016\/j.lfs.2006.01.007_bib14","first-page":"373","article-title":"Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke","volume":"13","author":"Komjati","year":"2004","journal-title":"International Journal of Molecular Medicine"},{"issue":"8","key":"10.1016\/j.lfs.2006.01.007_bib15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/sj.bjp.0704185","article-title":"Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences","volume":"133","author":"Liaudet","year":"2001","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.lfs.2006.01.007_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/taap.2000.8956","article-title":"Role of lipid peroxidation and poly(ADP-ribose) polymerase activation in oxidant-induced membrane transport dysfunction in opossum kidney cells","volume":"166","author":"Min","year":"2000","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"6","key":"10.1016\/j.lfs.2006.01.007_bib17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/01.STR.0000017284.77838.87","article-title":"Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment. An in vitro experimental approach","volume":"33","author":"Molinaro","year":"2002","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.lfs.2006.01.007_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.7326\/0003-4819-94-2-236","article-title":"Pathophysiology of acute myocardial infarction, 1981","volume":"94","author":"Oliva","year":"1981","journal-title":"Annales of Internal Medicine"},{"issue":"4","key":"10.1016\/j.lfs.2006.01.007_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF03401936","article-title":"Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption","volume":"6","author":"Pieper","year":"2000","journal-title":"Molecular Medicine"},{"issue":"2","key":"10.1016\/j.lfs.2006.01.007_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/hc0202.102248","article-title":"Activated monocytes induce smooth muscle cell death: role of macrophage colony-stimulating factor and cell contact","volume":"105","author":"Seshiah","year":"2002","journal-title":"Circulation"},{"issue":"9\u201310","key":"10.1016\/j.lfs.2006.01.007_bib21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0891-5849(99)00151-3","article-title":"Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia\u2013reperfusion in perfused rat heart","volume":"27","author":"Szabados","year":"1999","journal-title":"Free Radical Biology and Medicine"},{"issue":"5","key":"10.1016\/j.lfs.2006.01.007_bib22","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1073\/pnas.93.5.1753","article-title":"DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite","volume":"93","author":"Szabo","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.lfs.2006.01.007_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cardiores.2003.09.029","article-title":"Poly(ADP-ribose) polymerase activation in the reperfused myocardium","volume":"61","author":"Szabo","year":"2004","journal-title":"Cardiovascular Research"},{"issue":"5","key":"10.1016\/j.lfs.2006.01.007_bib24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00024382-200405000-00005","article-title":"INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation","volume":"21","author":"Szabo","year":"2004","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.lfs.2006.01.007_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1073\/pnas.94.2.679","article-title":"Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia\u2013reperfusion injury in the heart and skeletal muscle","volume":"94","author":"Thiemermann","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.lfs.2006.01.007_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.54.3.375","article-title":"The therapeutic potential of poly(ADP-ribose) polymerase inhibitors","volume":"54","author":"Virag","year":"2002","journal-title":"Pharmacological Reviews"},{"issue":"3","key":"10.1016\/j.lfs.2006.01.007_bib27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1124\/jpet.104.077164","article-title":"Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure","volume":"312","author":"Xiao","year":"2005","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.lfs.2006.01.007_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00024382-200013010-00011","article-title":"Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia\u2013reperfusion injury","volume":"13","author":"Yang","year":"2000","journal-title":"Shock"},{"issue":"5147","key":"10.1016\/j.lfs.2006.01.007_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.8080500","article-title":"Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity","volume":"263","author":"Zhang","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.lfs.2006.01.007_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0008-6363(97)00137-5","article-title":"Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase","volume":"36","author":"Zingarelli","year":"1997","journal-title":"Cardiovascular Research"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320506000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320506000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T20:15:13Z","timestamp":1627071313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320506000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0024320506000476"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2006.01.007","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}